[1] |
Zhu Y,Pandya BJ,Choi HK.Prevalence of gout and hyperuricemia in the US general population:the National Health and Nutrition Examination Survey 2007-2008[J].Arthritis Rheum,2011,63(10):3136-3141.
|
[2] |
Trifirò G,Morabito P,Cavagna L,et al.Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009:a nationwide population-based study[J].Ann Rheum Dis,2013,72(5):694-700.
|
[3] |
Uaratanawong S,Suraamornkul S,Angkeaw S,et al.Prevalence of hyperuricemia in Bangkok population [J].Clin Rheumatol,2011,30(7):887-893.
|
[4] |
Liu R,Han C,Wu D,et al.Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014:a systematic review and meta-analysis[J].Biomed Res Int,2015,2015:762820.
|
[5] |
Roddy E,Doherty M.Epidemiology of gout[J].Arthritis Res Ther,2010,12(6):223.
|
[6] |
Okura T,Higaki J,Kurata M,et al.Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis:subanalysis of the Japanese Coronary Artery Disease(JCAD) Study[J].Circ J,2009,73(5):885-891.
|
[7] |
靳晖.慢性肾脏病患者心血管疾病的发生规律及相关性研究[D].青岛:山东大学,2014.
|
[8] |
孙岗.联合透析(PHD)改善ESRD患者心脏结构及功能的研究进展[D].苏州:苏州大学,2018.
|
[9] |
Myers GL,徐国宾,林文涛,等.美国临床生化科学院检验医学实践指南;心血管疾病和卒中一级预防中新的生物标志物第7章肾功能标志物与心血管疾病危险[J].临床检验杂志,2013,31(5):387-392.
|
[10] |
Fang J,Alderman MH.Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study.1971.1992.National Health and Nutrition Examination Survey[J].JAMA,2000,283(18):2404-2410.
|
[11] |
Niskanen LK,Laaksonen DE,Nyyssonen K,et al.Uric acid level as a risk factor for cardiovascular and all cause mortality in middle-aged men:a prospective cohort study[J].Arch Intern Med,2004,164(14):1546-1551.
|
[12] |
Johson RJ,Kang D,Feig DI.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease[J].Hypertension,2003,41(6):1183.
|
[13] |
Alderman MH,Aiyer KJ.Uric acid:role in cardiovascular disease and effect of losartan[J].Curr Med Res Opin,2004,20(3):369-379.
|
[14] |
党爱民,刘国仗.尿酸与心血管事件[J].中华心血管病杂志,2003,31(6):478-480.
|
[15] |
高阿妮.不同尿酸水平与代谢综合征及冠心病相互关系的分析[D].大连:大连医科大学,2012.
|
[16] |
胡楠.清脂通脉颗粒对大鼠脂质代谢异常及抗动脉粥样硬化作用机制研究[D].沈阳:辽宁中医药大学,2019.
|
[17] |
徐卫锋.高尿酸血症通过调控肾上皮钠通道(ENaC)介导高血压发生的机制研究[D].南京:南京医科大学,2015.
|
[19] |
孙沙沙,洛佳坤,马宇飞,等.高尿酸血症与高血压关系的研究进展[J].中华老年心脑血管病杂志,2020,22(3):321-322.
|
[20] |
刘勇.慢性肾脏疾病与高尿酸血症的相关性研究[D].芜湖:皖南医学院,2014.
|
[22] |
张琨.维持性血液透析患者心血管疾病患病情况及危险因素分析[D].郑州:郑州大学,2017.
|
[18] |
Bickel C,Ruppreeht HJ,Blankenberg S,et al.Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease[J].Am J Cardiol,2002,89(1):12-17.
|
[21] |
Saggiani F,Pilsti S,Targher G,et al.Serum uric acid and related factors in 500 hospitalized subjects[J].Metabolism,1996,45(12):1557-1567.
|
[23] |
Goldberg IJ,Kaufman AM,Lavarias VA,et al.High flux dialysis menrbrbranes improve plasma lipoprotein profile in patients with end-stage renal disease [J].Nephrol Dial Traslant,1996,11(2):s104.
|